Schear Investment Advisers’s Boston Scientific BSX Stock Holding History

Schear Investment Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.5M	Buy	39,882 +12,370	+45%	+$990K	1.1%	32
2025 Q4	$2.62M	Buy	27,512 +1,736	+7%	+$170K	1.13%	27
2025 Q3	$2.52M	Buy	25,776 +233	+0.9%	+$24.1K	1.12%	27
2025 Q2	$2.74M	Buy	25,543 +1,293	+5%	+$131K	1.36%	20
2025 Q1	$2.45M	Buy	24,250 +1,144	+5%	+$115K	1.41%	20
2024 Q4	$2.06M	Buy	23,106 +3,336	+17%	+$294K	1.1%	23
2024 Q3	$1.66M	Buy	19,770 +1,727	+10%	+$136K	1.03%	31
2024 Q2	$1.39M	Buy	18,043 +1,629	+10%	+$119K	1%	31
2024 Q1	$1.12M	Buy	16,414 +2,010	+14%	+$129K	0.9%	36
2023 Q4	$833K	Buy	14,404 +100	+0.7%	+$5.34K	0.8%	42
2023 Q3	$755K	Sell	14,304 -412	-3%	-$21.6K	0.81%	43
2023 Q2	$796K	Buy	14,716 +771	+6%	+$40.3K	0.84%	42
2023 Q1	$698K	Buy	13,945 +112	+0.8%	+$5.28K	0.83%	42
2022 Q4	$640K	Buy	+13,833	New	+$599K	0.79%	46

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Schear Investment Advisers's BSX Position: Q1 2026 in Review

Schear Investment Advisers increased its Boston Scientific (BSX) stake by 45% in Q1 2026, buying an estimated $990K and bringing the position to 39,882 shares worth $2.5M. The position accounts for 1.1% of the portfolio, ranked #32.

Schear Investment Advisers first reported a position in BSX in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.74M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Schear Investment Advisers held 39,882 shares of Boston Scientific worth $2.5M as of Q1 2026.
Schear Investment Advisers bought 12,370 Boston Scientific shares in Q1 2026, an estimated $990K.
Boston Scientific made up 1.1% of Schear Investment Advisers's portfolio in Q1 2026, its #32 holding.
Schear Investment Advisers first reported a position in Boston Scientific in Q4 2022 and has held it in 14 quarters since.
Schear Investment Advisers's Boston Scientific position peaked at $2.74M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Schear Investment Advisers's 13F filing for Q1 2026, filed 28 Apr 2026.